HAYWARD, Calif., Feb. 5, 2013 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the appointment of Owen Hughes, Jr. , to the position of Chief Business Officer (CBO) and Head of Corporate Development. Mr. Hughes joins Intarcia from Brookside Capital, a multi-billion dollar hedge fund under the Bain Capital umbrella, where he served as a Director, co-managing all public and private healthcare investments. In his new position, Mr. Hughes will report directly to Intarcia Chairman, President and CEO Kurt Graves .
"I've known and respected Owen for many years for three key reasons. The first is his penetrating insights and tenacious 'in-it-to-win-it' spirit that will drive significant progress and results for our patients, our people, and our investors," said Mr. Graves. "The second quality is Owen's leadership, external focus and team-building demeanor that fits perfectly into our culture. Third, he is broadly plugged into where healthcare and technology is going and has built valuable relationships with many key players that will be important for our future success. We are thrilled to have him join our team!"
Mr. Hughes' leadership position is newly created at Intarcia and focuses on strategic planning, business operations, as well as oversight of all strategic transactions and business building collaborations. A primary objective will be to build an exciting pipeline with the Company's proprietary technology platforms. He will also work closely with the marketing team as Intarcia builds out new and forward-looking commercial models that fit the rapidly changing healthcare environment. Mr. Hughes' talents should prove very helpful to the Company during a time of in
|SOURCE Intarcia Therapeutics, Inc.|
Copyright©2012 PR Newswire.
All rights reserved